REQUEST A DEMO
Total
USD $0.00
Search more companies

Synex Biotech Private Limited (India)

Main Activities: Other Nonmetallic Mineral Product Manufacturing
Full name: Synex Biotech Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Synex Biotech Private Limited is based in India, with the head office in Dhar. The company operates in the Other Nonmetallic Mineral Product Manufacturing industry. The company was established on September 06, 2011. From the latest financial highlights, Synex Biotech Private Limited reported a net sales revenue increase of 15.45% in 2025. A growth of 21.31% was recorded in its total assets. In, 2025, the company’s net profit margin increased by 2.21%.

Legal Address
Plot No. 66-A Sector -3 Industrial Area
Dhar; Madhya Pradesh; Postal Code: 454774

Contact Details: Purchase the Synex Biotech Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Synex Biotech Private Limited report to view the information.
Financial Auditors:
Purchase the Synex Biotech Private Limited report to view the information.
Incorporation Date:
September 06, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
27%
Purchase this report to view the information.
13%
Company Performance
Financial values in the chart are available after Synex Biotech Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
15.45%
Total Operating Revenue
16.43%
Operating Profit
61.71%
EBITDA
53.6%
Net Profit/Loss for the Period
279.2%
Total Assets
21.31%
Total Equity
215.58%
Operating Profit Margin
1.84%
Net Profit Margin
2.21%
Return on Equity (ROE)
2.77%
Debt / Equity
-285.97%
Quick Ratio
-0.08%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?